Clinical Trial Details
EORTC-30845
Back to Clinical Trials Database
Phase III trial of BCG-RIV vs mitomycin-C in primary and recurrent Ta-T1 papillary carcinoma and primary carcinoma in situ of the urinary bladder
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date Step1 close: 01-Oct-1986 |
| Data management at EORTC | |
| Design |
Phase 3 Randomized open label |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/ |
| NCT number |
